e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
New targets and modalities for the treatment of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma
Anna-Karin Larsson-Callerfelt (Lund, Sweden), Anna-Karin Larsson-Callerfelt, Maria Weitoft, Leif Bjermer, Ellen Tufvesson, Gunilla Westergren-Thorsson
Source:
International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Session:
New targets and modalities for the treatment of asthma and COPD
Session type:
Poster Discussion
Number:
2126
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anna-Karin Larsson-Callerfelt (Lund, Sweden), Anna-Karin Larsson-Callerfelt, Maria Weitoft, Leif Bjermer, Ellen Tufvesson, Gunilla Westergren-Thorsson. iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma. Eur Respir J 2015; 46: Suppl. 59, 2126
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
iNOS expression is increased in peripheral airways of asthmatic patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Airway epithelial hemoglobin beta regulates ciliary endothelial NOS
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Activation of TLR3 augments the production of MMPs in human lung fibroblasts via iuducible NOS dependent pathway
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Nitric oxide oxidation products in bronchoalveolar lavage of patients with different severity of asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Decreased airway eosinophilic inflammation, hypersecretion and remodeling in mice lacking all nitric oxide synthase isoforms
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD)
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Source: Eur Respir J 2006; 27: 951-956
Year: 2006
Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 432s
Year: 2006
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Source: Eur Respir J 2003; 21: 394-400
Year: 2003
Exhaled nitric oxide in infants: a marker of inflammation?
Source: Eur Respir Monogr 2010; 49: 56-70
Year: 2010
Association of free radical formation, severity of disease and degree of systemic inflammation in patients with bronchial asthma
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept